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Although much information has been accumulated on the process of cytolysis 
by thymus-dependent (T) 1 lymphocytes, the precise biochemical basis for the 
lytic mechanism is  still  unclear.  The  present knowledge of the  subject has 
recently received extensive review (1-3).  Three approaches have been adopted 
for the study of the metabolic processes essential for T-cell-mediated cytolysis. 
First, experiments have been carried out using support media which have been 
deprived of primary metabolic substrates. For example, assessment of cytolysis 
has been performed in glucose-free medium, under anaerobic conditions (4), or 
in the absence of divalent cations (5). Second, drugs have been used to block 
cytolysis and the findings have been interpreted in relation to the reported 
major effects of these drugs on metabolic processes.  However,  in general no 
control has been provided to indicate that the observed effect on cytolysis was 
causally linked to the reported metabolic effects. This approach has been fully 
reviewed by Martz (2). Finally, competitive inhibitors have been used, with a 
check on the specificity of their action through reversal of their effect with 
excess normal substrate.  Probably the best example of such an approach has 
been the recent work of MacDonald (6) using 2-deoxy-D-glucose as an inhibitor 
of cytolysis,  and  D-glucose  or  D-glucose  analogs  to  achieve  reversal.  These 
results appear to have formally established a role for glucose or a glucose analog 
in T-cell-mediated cytolysis. Interestingly, some of MacDonald's results indi- 
cated that glucose might not be acting simply as an energy source. 
Most previous investigations with drugs, including 2-deoxy-D-glucose,  have 
failed to establish at which stage(s) of cytolysis the agents were acting. T-cell- 
mediated cytolysis can now be considered as a complex phenomenon including 
a number of discrete stages (7, 8). The first recognition stage is followed by the 
"lethal hit" stage during which an irreversible lesion is inflicted upon the target 
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cell by the effector cell. This is in turn followed by the target cell disintegration 
stage. Our approach to an analysis of these various stages makes use of a "Ca  ++ 
pulse" method (3, 9). This method is based on the observation that although the 
cytolytic process as a  whole requires  Ca  ++  (5,  9-13),  the  recognition stage can 
proceed in the presence of Mg  ÷+ only (9,  13,  14), and neither Ca  ++ nor Mg  ++ are 
required  at  the  disintegration  stage  (5,  8,  10,  15,  16).  Ca  ++,  therefore,  is 
necessary  only  at  the  lethal  hit  stage  (9,  13).  Consequently,  the  successive 
addition  of Mg  ++,  Ca  ++,  and finally EDTA,  provides a  simple and convenient 
way  of  isolating  and  studying  the  lethal  hit  stage  (9).  It  can  be  used  to 
investigate the impact of drugs at various stages of the lytic process (3). 
In  this  study  we  investigated  the  carbohydrate  requirement  of T-cell-me- 
diated cytolysis and showed:  (a) using chemically defined media or the compet- 
itive  inhibitor  2-deoxy-D-glucose,  that  glucose  or  certain  glucose  analogs  are 
required  for  the  cytolytic  process;  (b)  using  the  Ca  ++  pulse  technique  and 
cytochalasin A, which is a  selective inhibitor of recognition,  that the carbohy- 
drate requirement for cytolysis can be localized at the lethal hit stage; (c) that 
cytolysis can  also take  place  in  phosphate-buffered  saline  plus  dialyzed  fetal 
bovine serum without added glucose but even in this support medium cytolysis 
is blocked by 2-deoxy-D-glucose; (d) by studying the three main energy-produc- 
ing pathways of carbohydrate catabolism, that a  major requirement for carbo- 
hydrate in T-cell-mediated cytolysis is independent  of its capacity to act as an 
energy source. 
Materials  and  Methods 
Media.  RPMI-1640 (Gibco Bio-Cult,  Glasgow,  Scotland)  was  used  as the  standard  tissue 
culture medium and as a diluent.  Low phosphate-buffered  saline  (LPBS) was made up as an 
aqueous solution containing 137 mM NaC1, 2.7 mM KC1, 1.5 mM K2HPO4, 3.2 mM Na~HPO~ (12 
H~O), 1 mM CaCl~, 0.5 mM MgC12 (6 H20), and 10 mg/1 of phenol red. Heat-inactivated (56°C, for 
30 min) fetal bovine serum (FBS) (batch 802.42; Eurobio, Paris, France) was used as such or (after 
dialysis against 100  vol of LPBS with two  changes  over three 24-h periods)  as dialyzed  FBS 
(DFBS). 
Chemicals.  Chemicals  used were D-glucose (Prolabo,  Paris,  France),  2-deoxy-D-glucose  and 
cytochalasin  A  (Aldrich  Chemical  Co.,  Inc., Milwaukee,  Wis.),  lactate-dehydrogenase (LDH) 
from pig heart,  and  B-nicotinamide  adenine  dinucleotide  (~NAD)  grade  1,  both from C.  F. 
Boehringer and Sons (Mannheim,  W. Germany), and hydrazine hydrate (98% pure; Merck AG, 
Darmstadt, W. Germany). D-[1-14C]glucose (sp act 4-15 mCi/mM), D-[6-14C]glucose  (sp act 3.0 mCi/ 
mM), and 2-deoxy-D-[1-14C]glucose (sp act 59 mCi/mM) were obtained from the Radioehemical 
Centre (Amersham, England).  Sodium :'lCr-chromate (sp act >50 mCi/mg) was obtained from the 
Commissariat ~ l'Energie Atemique (Gif-sur-Yvette,  France). 
Preparation of Sensitized Spleen Cell Populations  Containing Cytolytic T Cells.  C57BL/6 anti- 
DBA/2 (H-2 ~' anti-H-2 '~, b anti-d for short)  cell populations  containing cytolytic T cells, and the 
reciprocally sensitized d anti-b cells were obtained by mixed lymphocyte culture as follows. Mouse 
splenic responder cells (2 × 107) and irradiated (2,000 rads) allogeneic splenic stimulating cells (2 
x  10  ~) were coincubated  (37°C in 5% CO2 atmosphere, for 4-5 days) in an upright plastic flask 
(Falcon 3013; Falcon Plastics,  Div. of BioQuest, Oxnard,  Calif.) in a 20-ml vol of RPMI-1640 with 
10% FBS, 50 U/ml of penicillin,  50 ~g/ml of streptomycin,  2 mM L-glutamine,  and 2 × 10 -~ M 2- 
mercaptoethanol. The sensitized cell populations were used for cytolysis and metabolic tests. It is 
amply documented  that the cytolysis obtained under these sensitization conditions  and using a 
short-term assay (see below) is due to T cells (17, 18). It should be stressed that these populations 
sensitized in vitro contain only a small minority of cytolytic T cells (19) with other T cells, and 30- 
40% of non-Thy 1-bearing cells (unpublished  observations). 
Cytolysis  Tests.  All the assays were done in Cooke microtiter plates with V-shaped  wells IAN  C.  M.  MacLENNAN  AND  PIERRE  GOLSTEIN  1553 
(Cooke  Laboratory  Products,  Div.  Dynatech  Laboratories  Inc.,  Alexandria,  Va.),  each  well 
receiving 2 ×  105 washed, sensitized cells and 104 twice-washed P 815 (d mastocytoma) cells which 
had been slCr-labeled overnight (20).  Upon addition of both types of cells, the microplates were 
briefly centrifuged (200 g, 2 min) to hasten cell-to-cell contacts (20,  21).  Incubation was for 4 h at 
37°C unless stated otherwise. 
In standard assays, target and effector cell populations were washed and resuspended in LPBS 
and mixed in the cold. Each V-shaped well received successively (a) 50/~l of drug and/or nutrient 
solution,  (b) 50 /~l of the cell mixture (followed by centrifugation),  (c) after 1 h  of incubation at 
37°C,  50 ~l of 12 mM EDTA to stop further cytolysis (16),  (d) 5 min afterwards,  50/~l of RPMI- 
1640 with 10% FBS. The plates were incubated for 3 h at 37°C after the addition of EDTA to allow 
~'Cr to be released from injured cells.  Cell feeding under EDTA cover, after the initial cytolytic 
stages, allowed exacting media to be tested while the level of spontaneous :"Cr release was kept 
low. 
In Ca ++ pulse assays (3, 9), target and effector cell populations were washed and resuspended 
in RPMI-1640 with 1% FBS, 1 mM Mg  ÷+ (as MgC12), and 1 mM of ethylene glycol bis(B-aminoethyl 
ether) N,N,N',N'-tetraacetic acid (EGTA; Sigma Chemical Co., St. Louis, Mo.). The presence of 
EGTA ensured neutralization of the Ca +* contained in RPMI-1640, while Mg  ++ was still available 
in excess to the cells. The cell populations were mixed in the cold. Each V-shaped well received 
successively  (a)  50  /~l  of  the  cell  mixture  (followed  by  centrifugation),  (b)  after  a  40-min 
incubation at 37°C,  50/~l of Ca ++ as CaC12 solution to a  final concentration of 1 mM,  (c) after a 
further  20-min  incubation  at  37°C,  50  /~l  of  12  mM  EDTA.  Glucose  solutions  at  various 
concentrations were  added  as  a  50-/~1 fraction per well  either ab  initio,  or  10 min before the 
addition of Ca ++ (prepulse), or just after the addition of EDTA (postpulse). Protocols of individual 
experiments differing from this general outline are described in Results.  The plates were incu- 
bated for 3 h  at 37°C  after the addition of EDTA. 
At the end of the incubation period, the plates were centrifuged again, the radioactivity of a 
100-/~l aliquot from each well was compared with the initial radioactivity of 5  ×  103 target cells, 
and  cytolysis  was  expressed  as  the  averaged  percentage  of ~'Cr released  from  target  cells  in 
triplicate wells. 
Measurement of  Lactate Production.  Sensitized spleen cells were incubated in V-shaped wells 
of microplates (per well, 4  ×  l{Y  ~ cells for 3 h, or 10  ~ cells for 1 h, at 37°C in a  total volume of 100 
~l  of LPBS  containing  the  nutrients  mentioned  in  Results).  At  the  end  of the  incubation, 
perchloric acid was added to achieve 2% vol/vol in a  total volume of 200 ~l/well. The plates were 
centrifuged,  and  150-/~1 supernatant aliquots  were transferred to new microplate wells.  These 
aliquots were brought to pH between 6  and 8  (estimated by phenol red in medium) with 20% 
KOH,  and then stored at 4°C for 15 min. The plates were then centrifuged, and 100-/~l aliquots 
were added to tubes containing 100 #l 2% vol/vol flNAD,  1 ml of Tris-hydrazine buffer, pH 9.5, 
and water to 2.97 ml. The optical density of these solutions was read at 340 nm in 1-cm cuvettes 
(E  s4° 1 cm). A 30-pJ volume of the LDH solution was then added, and the E 34° 1 cm of solutions was 
read after 30 rain and again after 40 min to check stability. The difference between the initial and 
final spoctrophotometer readings was then subtracted from the medium only blank reading to give 
AE.  The lactate present was calculated using the molar extinction coefficient of NADH.  Lactate 
standards were included in experiments. The averaged results for duplicate wells were expressed 
as nanomoles of lactate produced per 10" cells per h. 
Measurement  of  ~4C0  2 Production  from  D-[1-'4C]Glucose, D-[6-'4C]Glucose and  2-Deoxy-[1- 
14C]Glucose.  Sensitized spleen cells were  incubated in 6  ×  40-mm pelystyrene  tubes  (RT  15; 
Sterilin, Teddington, Middlesex,  England) placed in rubber cap-sealed scintillation vials (Inter- 
technique,  Plaisir,  France).  Conditions for incubation were  the same  as for the  lactate assay 
except that 0.025  ~Ci of ['4C]glucose was added to each RT  15 tube.  In most experiments, cold 
glucose was included in excess as specified in Results, At the end of the incubation period, a 200- 
/~l volume of 0.5 M  KOH was injected through the rubber seal into each vial outside the RT 15 
tube. A  100-/~l volume of 30% perchloric acid was then injected into each RT 15 tube. The vials 
were incubated in a  shaking water bath for 1 h  at 37°C  to allow all CO2 to be absorbed by the 
KOH. The RT 15 tubes were then removed and scintillation fluid (5 ml) was added directly to each 
vial. The amount of CO2 produced from carbon 1 or 6 of D-glucose, termed 1-C.CO2  and 6-C.CO2 
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counts per minute measured 
counts per minute added  × nanomoles D-glucose added. 
(This made no allowance for glucose recycled from the pentose cycle and diluting ~-[1-14C]glucose, 
but in the experiments quoted, the total glucose added to cultures was sufficiently large to make 
this a minor error.) The main purpose of the metabolic measurements in this study was to gain 
information about the doses  of drugs which effectively stop and the levels of nutrients which 
effectively support  energy  production  by  the  three  major  glycolytic pathways.  Only  rough 
estimates of absolute traffic could be derived from the data presented. Methods of calculating the 
relative activity of the main glucose  utilization pathways were discussed in detail by Katz and 
Wood (22). Measurements of 1-C.CO2, 6-C.CO2, and lactate production were expressed as nmol/10" 
cells/h. 
Repetition of Experiments.  All cytolysis and metabolic experiments reported were carried out 
at least three times yielding similar results. All nutrient and drug solutions were prepared fresh 
for each assay. 
Results 
The Relative Contribution  of  Different Metabolic Pathways to Energy Produc- 
tion in Sensitized Spleen  Cells at Different  Glucose Concentrations.  To set a 
basis for the studies of carbohydrate utilization during cytolysis, the relative 
contribution of the main metabolic pathways of energy production in sensitized 
spleen cells was examined. Although the metabolic activity of cytolytic T cells 
is  not  necessarily  reflected  by  the  sum  activity  of 5-day  one-way  mixed 
lymphocyte cultures, it was considered that these measurements would provide 
a better indication of the active dose range of metabolic inhibitors than could be 
obtained from reports of previous studies on totally different cell populations. 
Sensitized spleen cells (10  ~) were incubated for 3 h in a total volume of 100 t~l of 
LPBS in the presence of different concentrations of D-glucose, after which the 
amount of metabolites produced was assessed (Table I). 
Lactate production of >4 mM glucose (800 nmol/culture) was constant, and 
the relative contribution of the pentose cycle to lactate production was well 
under 5%. Lactate production was markedly less when limiting glucose concen- 
trations were used, with a corresponding increase of the relative importance of 
the pentose cycle and Krebs cycle. Experiments using lower concentrations of 
glucose in I00-td cultures showed that lactate production was below the level of 
sensitivity of the  assay used at ----0.05 mM glucose.  This value is useful for 
interpreting experiments (described below) on the supportive role of DFBS in 
cytolysis. 
The Carbohydrate  Requirement of T-Cell-Mediated  Cytolysis.  Two lines of 
evidence strongly suggested that D-glucose (or one of its metabolites or analogs) 
was required for T-cell-mediated  cytolysis. First, good levels of specific cytolysis 
could be produced in LPBS plus D-glucose, but there was no detectable cytolysis 
in LPBS  alone  (Fig.  1).  Second, 2-deoxy-D-glucose was able to competitively 
inhibit cytolysis when in excess over glucose (Fig.  2). It was possible  to delay 
the addition of glucose for 40 min in cultures initiated in LPBS and still get 
cytolysis (Table  II,  group  1).  This  showed that  glucose deprivation was not 
immediately lethal for the cytolytic T cells. Furthermore, the blocking effect of 
2-deoxy-D-glucose added ab initio could be reversed by the addition of excess 
glucose  40  min  later  (Fig.  3).  This  indicated  a ,complete  reversibility  by 
glucose of the 2-deoxy-D-glucose block of cytolysis. Taken together, these results IAN  C.  M.  MacLENNAN  AND  PIERRE  GOLSTEIN  1555 
TABLE  I 
Assessment of l-C.CO2, 6-C.C02, and Net Lactate Production by Sensitized Spleen 
Cells Cultured in LPBS Plus Varying Concentrations of Glucose 
Glucose concentration (mM) 
Production of* 
16  8  4  2  1  0.5 
Lactate  30  30  29  25  18  7 
1-C.CO2  3.9  4.5  6.6  6.2  5.9  4.6 
6-C.CO2  0.24  0.24  0.31  0.31  0.26  0.24 
* Results are expressed in nmol/10  ~ cells/h. 
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FIG.  1,  Concentration of D-glucose  able  to  support  T-cell-mediated  cytolysis  in  LPBS. 
Each culture contained 104 target cells  (P 815 of H-2 '1  origin) and 2  ×  1{~  ~ effector cells. 
Cytolysis mediated by b anti-d (D) and d  anti-b (+) effector cells. 
showed that glucose was required to support cytolysis and not just to ensure 
cytolytic cell survival. 
The Stage  of the  Cytolytic Process Where Glucose is Required.  Calcium 
pulse experiments were carried out to see if glucose was required for the Ca ÷+- 
dependent lethal hit stage of cytolysis. 2-deoxy-D-glucose was added to glucose- 
containing effector cell-target cell mixtures, either ab initio, 10 min before the 
Ca  ++ pulse, or just after the Ca ++ pulse. Block occurred with prepulse but not 
with postpulse addition of 2-deoxy-D-glucose (Fig.  4).  This type of experiment 
indicated that glucose was required at the lethal hit stage but did not give 
information about possible glucose requirements at the recognition stage. To 
investigate this, the drug cytochalasin A was used. At appropriate concentra- 
tions,  this  agent inhibits recognition but  not the  Ca++-dependent lethal  hit 
stage  (23).  2 Cell mixtures were set up in LPBS only, and glucose was added 
either before or after the addition of cytochalasin A. The'detailed protocol of the 
2 p. Golstein, C. Foa, and I. C. M. MacLennan. 1978.  Mechanism of T-cell-mediated cytolysis: 
the differential impact of cytochalasins at the recognition and lethal hit stages. Eur. J. Immunol. 
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FIG.  2.  Concentration of 2-deoxy-D-glucose required to inhibit (a) specific T-cell-mediated 
cytolysis; (b) lactate production by sensitized T cells.  Cytolysis mediated by b anti</ ([]) 
and d anti-b  (+) effector cells. (©), Lactate production by b anti</cells. The basic culture 
medium was LPBS  +  3 mM D-glucose. 
TABLE II 
Lack of Glucose Requirement for the Cytochalasin A-Dependent Stage of Recognition 
Group 
Time (min~ of  culture addition* 
Cytolysis  ofd target  cells 
by the following effector 
cells$ 
Pre 0  0  30  40  60  65  b anti-d  d  anti-b 
1  LPBS  Cells in  LPBS  Glucose  EDTA  RPM!  28.8  16.2 
LPBS  10% FBS 
2  LPBS  Cytochalasin A  25.3  14.9 
3  Cytochalasin A  LPBS  18.2  15.3 
4  LPBS  LPBS  LPBS  17.1  16.7 
5  Glucose  Cytochalasin A  26.2  16.1 
* Additions at time pre 0, 0, 30, and 40 min in 25 ~1. Additions at 60 and 65 rain in 50 ~1. No serum additive was used before 65 
min. Cultures were harvested at 4 h. 
$ Cytolysis expressed  as percent '~Cr release  Lmeans  of quadruplicate cultures). 
experiment and its results are shown in Table II. A  comparison of groups 2 and 
5 in particular indicated that the cytochalasin A-inhibitable step did not require 
glucose. Taken together, these experiments showed that D-glucose was required 
during  the  lethal  hit  stage  of cytolysis,  but  was  not  required  at  either  the 
cytochalasin A-inhibitable  recognition stage,  nor the ~'Cr release  stage. IAN  C.  M.  MacLENNAN  AND  PIERRE  GOI.~TEIN  1557 
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FIG.  3.  Ability of D-glucose to reverse the inhibition of cytotoxicity induced by 2-deoxy-D- 
glucose. All  cultures were set up with  104 P  815 and 2  ×  105 b  anti~  cells in RPMI-1640 
(11.5  mM  D-glucose)  with  1%  FBS  plus  the  dilutions  of 2-deoxy-v-glucose  shown.  The 
cultures were then centrifuged and incubated for 40 min at 37°C before glucose supplements 
were added to the culture: no supplementary D-glucose (@),  18 mM D-glucose (A), 72 mM 
glucose (©).  Cultures were harvested 3 h  later. 
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FIG. 4.  The stage  of  T-cell-mediated  cytolysis  inhibited  by 2-deoxy-D-glucose.  Cultures  of 
104  P 815 and 2 x 105  effector  cells  were set  up in  RPMI-1640 + I% FBS, i  mM  EGTA, and 
1.5 mM  Mg  ++ to allow binding without lysis.  After 40 min, Ca  *+ was added (final 
concentration 1 raM) to initiate  the lethal  hit. 20 rain  later,  EDTA  was added (final 
concentration 3 raM). Cultures were harvested 3 h later.  (/x),  b anti-d effector  cells,  2- 
deoxy-D-glucose added after  EDTA; ([~),  b anti-d  effector  cells,  2-deoxy-v-glucose  added ab 
initio;  (0),  b anti-d  effector  cells,  2-deoxy-D-glucose  added before  Ca  ++  pulse;  (+),  d anti-b 
effector  cells,  2-deoxy-D-glucose  added ab initio. 
Three Lines  of Evidence  Suggesting  that the Role of D-Glucose  in  T-Cell- 
Mediated Cytolysis Is Unrelated to Its Capacity to Provide Energy 
2-DEoxY-D-GLUCOSE,  WHICH BLOCKS CYTOLYSIS~ CAN ACT AS AN ENERGY SOURCE. 
The experiments exemplified in Fig. 2 clearly showed the efficiency  of 2-deoxy- 1558  HEXOSE  REQUIREMENT  FOR  T-CELL-MEDIATED  CYTOLYSIS 
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Fro.  5.  Failure of 2-deoxy-D-glucose to inhibit 1-C.CO2 production from the 1-C atom of 
glucose by b  anti-d effector cells.  Medium used was 5 mM D-glucose in  LPBS.  1-C.CO2 
production  (A  A),  net  lactate  production  (©  0)  with added 2-deoxy-D-glucose; 1- 
C.CO~ production (A- -  -  A), net lactate production (©- -  -O) with added mglucose. 
D-glucose at blocking lactate production. However, as this agent does not block 
the cytochrome system (24), it could be a source of energy via the pentose cycle, 
provided that it did not prevent the reduction of NADP in the first or second 
enzymatic steps of this cycle. This was investigated in two ways.  First,  the 
effect of 2-deoxy-D-glucose on 14CO2 production from D-[1-14C]glucose by sensi- 
tized spleen cells was assessed.  Fig.  5 shows that 2-deoxy-D-glucose, even at 
concentrations which inhibited lactate formation, did not significantly inhibit 
1-C.CO~ production from glucose.  The  second set  of experiments tested the 
relative amounts of ~4CO2 produced from D-[1-14C]glucose and 2-deoxy-D-[1-~4C]  - 
glucose. These confirmed the previous experiments in that equivalent amounts 
of 14CO2 were produced from both radiochemicals (Table III).  This shows that 
2-deoxy-D-glucose could be processed through the first two enzymatic steps of  the 
pentose cycle and thus provide a potential energy source in the form of reduced 
NADP, which if transported to mitochondria, could be oxidized to yield ATP. 
OTHER  SUBSTRATES FOR ENERGY  METABOLISM DO  NOT  SUPPORT CYTOLYSIS.  A 
number  of known  substrates  for  energy metabolism  were  tested  for  their 
capacity to support T-cell-mediated cytolysis. These were glycerol, pyruvate, 
and  the  following  glycogenic amino  acids:  alanine,  arginine,  asparagine, 
glycine, histidine, phenylalanine, serine,  and valine.  They were assessed at IAN  C.  M.  MacLENNAN  AND  PIERRE  GOLSTEIN 
TABLE  III 
Ability of Sensitized Spleen Cells to Produce 1-C.C02 from 2-Deoxy-D- 
Glucose in the pentose cycle 
1559 
Culture conditions* 
2-Deoxy- 
[1.,4C]glucose  [1-'4C]Glucose  D-Glucose 
Production of 
1-C.'4CO~$ 
~Zl  wvl  mM 
0.5  -  5.6  0.96 
-  7.5  5.6  0.74 
* Sensitized cells are cultured in RPMI-1640 with either [1-'4C]D-glucose  or 2- 
deoxy-  [  1-'4C]D-glucose  added. 
$ Expressed as nmol CO2/10  ~ cells/h. 
TABLE IV 
Ability of Exogenous Pyruvate to Compete  with Pyruvate 
Produced by Glycolysis 
Release of* 
Pyruvate concentration (mM) 
10  3.3  1.1  0 
cprn 
6-C.~4CO2  65  126  210  626 
1-C.~4CO2  4,100  5,782  6,930  3,811 
* Cultures were set up in LPBS plus 0.5  mM glucose including either 
[1-~C]D-glucose or  [6-~4C]D-glucose. The radioactive CO2 released by 
the cultures was measured and is given here as counts per min (cpm). 
The rise in 1-C. CO2 production associated with pyruvate is considered 
in the discussion. 
final concentrations  of 10 mM in LPBS and three twofold dilutions from this. 
Positive control groups with D-glucose were included.  None of these substrates 
permitted  significant  T-cell-mediated  cytolysis,  whereas  D-glucose  supported 
significant cytolysis in each experiment  (not shown). Experiments were set up 
with pyruvate or a  mixture of glycogenic amino acids to see if the agents could 
be used as substrates  for aerobic metabolism.  Pyruvate strongly inhibited  6- 
C14CO2 production from glucose (Table IV), indicating that exogenous pyruvate 
could compete with cell-derived pyruvate as a substrate for energy metabolism. 
The ability of the glycogenic amino acids to act in this way was not clear from 
these  experiments  (not  shown).  An  overall  conclusion  from these  and  the  2- 
deoxy-D-glucose experiments  is  that  provision  of energy  without  glucose  or 
DFBS (see below) is not sufficient to support T-cell-mediated cytolysis. 
DIALYZED  FBS  CAN  SUPPORT  T-CELL-MEDIATED  CYTOLYSIS  IN  THE  ABSENCE  OF 
DETECTABLE LACTATE PRODUCTION.  Experiments  were set up to see if LPBS 
enriched  with  DFBS only,  without  added  glucose,  could support  cytolysis. It 
was found  (Fig.  6) that as little  as 0.03%  DFBS was able to do so.  This result 
immediately posed serious questions  in relation  to the glucose dependence  of 
cytolysis, for (a) thoroughly dialyzed FBS should contain no free glucose, and 
(b) there is insufficient nondialyzable carbohydrate in FBS for the agent to be 1560  HEXOSE  REQUIREMENT  FOR  T-CELL-MEDIATED  CYTOLYSIS 
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acting simply as a glucose source. Even if the mean carbohydrate content were 
10% of serum proteins (100 g/liter) and all were available hexose, there would 
be  only 0.017  mM  hexose in 0.03%  DFBS.  This  is  well below the minimum 
glucose  concentration able  to  support  cytolysis in  LPBS  (Fig.  2).  However, 
carbohydrates do appear to be essential in DFBS-supported cytolysis, since this 
was blocked by  2-deoxy-D-glucose  (Fig.  7).  Perhaps  even  more  interestingly, 
when  incubated  in  LPBS  plus  5%  DFBS  (an  excess  of >100-fold  over  the IAN C. M.  MacLENNAN  AND  PIERRE  GOLSTEIN 
TABLE  V 
Level of 2-Deoxy-D-Glucose Required to Inhibit Cytolysis in 
LPBS Plus Various Amounts of DFBS 
2-Deoxy-D-glu- 
cose 
DFBS (%) 
25  8  2  0.7 
mM 
10  17"  15  16  18 
3.3  17  16  17  17 
1.1  22  22  21  20 
0  30  33  33  33 
1561 
* Cytolysis expressed as percent :"Cr release from 104 d  target cells in 
the presence of 2  x  10  ~ b  anti-d-sensitized spleen cells. Percent :"Cr 
release in presence ofd anti-b cells is not shown but was in the range 
of that seen with b anti-d cells plus 10 mM 2-deoxy-D-glucose. 
TABLE VI 
Synergism between Glucose and DFBS in Overcoming the Block on Cytolysis  Induced 
by 2-Deoxy-D-Glucose 
2-Deoxy-D-glu- 
cose (mM) 
LPBS +  10% DFBS  LPBS +  6mMglucose 
16  8  4  0  16  8  4  0 
D-Glucose 
supplement 
mM 
0 
8 
16 
32 
4/4*  5/4  7/4  20/4  7/6  8/7  10/7  22/8 
17/5  22/5  24/6  20/4  10/6  14/7  17/8  22/6 
23/5  24/4  25/5  22/5  14/7  16/7  20/7  24/10 
24/5  23/5  23/5  24/6  19/9  21/8  21/8  26/12 
* Cytolysis expressed as percent :'~Cr release from 10  4  d target cells in presence of 2 × 10:' b anti-d/ 
d  anti-b effector cells. 
minimum DFBS concentration required to support cytolysis), sensitized spleen 
cells did not produce measurable levels of lactate (Fig.  7).  These experiments 
led us to two conclusions. First, whereas glucose did not seem to be involved in 
DFBS-supported cytolysis, as demonstrated by the quantitative considerations 
above,  and  by  the  absence  of lactate  production,  clearly something closely 
related to glucose must be involved because of the inhibitory effect of 2-deoxy-D- 
glucose.  Second, T-cell-mediated cytolysis could take place in the absence of 
detectable lactate production. 
Does DFBS Directly Provide  a  Necessary Substrate for Cytolysis?  To test 
this,  the  dose of 2-deoxy-D-glucose required to  block  cytolysis in  LPBS  plus 
dilutions of DFBS was assessed. The results of such an experiment are shown in 
Table  V.  The concentration of 2-deoxy-D-glucose required to  inhibit cytolysis 
was found to be independent of the amount of DFBS added to cultures. Such a 
result would seem to indicate that 2-deoxy-D-glucose is not competing directly 
with a  substrate in DFBS. 
Synergism  between  D-Glucose  and  DFBS.  A  consistent  observation  has 
been that it was far more difficult to inhibit cytolysis with 2-deoxy-D-glucose 
when both DFBS and D-glucose were present than when either supportive agent 1562  HEXOSE  REQUIREMENT  FOR  T-CELL-MEDIATED  CYTOLYSIS 
was  present  alone.  A  typical  experiment  is  illustrated  in  Table  VI.  This 
synergism is marked at DFBS concentrations >5%, but is not obvious with 1% 
DFBS in LPBS. This observation reinforces the conclusions drawn above that 
DFBS is acting neither as a direct glucose source nor simply as an agent for 
mobilizing glucose. 
Discussion 
Now that it is possible to isolate different stages of T-cell-mediated cytolysis, 
the task of unravelling the biochemical basis of the process has become more 
approachable.  This  is  exemplified in our study, which suggests an  absolute 
requirement for  glucose  or  a  glucose  derivative  during  cytolysis,  and  also 
indicates that this requireme~  t is confined to the calcium-dependent lethal hit 
stage of cytolysis. 
First,  is D-glucose really necessary for cytolysis? It seems from the experi- 
ments showing specific T-cell-mediated cytotoxicity in LPBS plus D-glucose, but 
not in LPBS alone, that D-glucose is able to satisfy some molecular requirement 
for  cytolysis.  But  these  experiments  do  not  tell  us  whether  D-glucose  is 
obligatory, or simply a substrate for synthesis which could be replaced by other 
molecules. At first the experiments showing lysis in LPBS with <0.1%  DFBS 
appeared to indicate that D-glucose was not obligatory. But the finding that 2- 
deoxy-D-glucose blocked cytolysis in this support medium returned the balance 
in favor of glucose involvement. However, we know that cytolysis only proceeds 
in LPBS plus D-glucose when the D-glucose concentration is >0.1 mM, and that 
there is insufficient carbohydrate in 0.04% dialysed FBS in LPBS to provide 
this level of D-glucose. Also,  the experiments showing no lysis in LPBS plus 
amino acids or pyruvate make it improbable that hexose could be synthesized 
from DFBS protein catabolism. This seems to leave three possible explanations 
for the mechanism of action of DFBS:  (a) that it mobilizes carbohydrate from 
the  cells,  (b)  that  DFBS  provides  a  carbohydrate molecule which  is  more 
efficient than glucose,  (c) that DFBS  increases the efficiency of cytolysis in 
some way, so as to reduce the requirement for glucose, for instance by bringing 
about  increased  cell-cell  binding.  The  second  of  these  possibilities  seems 
unlikely because the concentration of 2-deoxy-D-glucose needed to block cytoly- 
sis in LPBS plus dialyzed FBS is independent of the concentration of dialyzed 
FBS (Table V). This observation is, however, compatible with explanation (a), 
(c), or a combination of beth explanations. 
Another indirect line of evidence compatible with D-glucose requirement at 
the lethal hit stage comes from studies with cytochalasins. Both cytochalasin A 
and B will block cytolysis  when added to cultures ab initio, but only cytochalasin 
B inhibits when added after recognition and before the calcium pulse. 2 It is 
interesting that cytochalasin B, but not cytochalasin A blocks glucose utiliza- 
tion by sensitized spleen cells (25).  2 Perhaps the most convincing argument in 
favor of an absolute requirement for D-glucose or a D-glucose analog in cytolysis 
is the fact that 2-deoxy-D-glucose reversibly blocks cytolysis in complete culture 
medium (ref. 6 and Fig. 3). The selectivity of the reaction is further emphasized 
by MacDonald's observations (6) that many other hexoses and pyruvate fail to 
reverse  the  2-deoxy-D-glucose  block  of cytolysis.  Galactosamine,  galactose, IAN  C.  M.  MacLENNAN  AND  PIERRE  GOLSTEIN  1563 
fucose,  and  fructose all  failed to  reverse the block.  However,  it  is  of great 
interest that 5-thio-D-glucose and mannose could reverse this inhibition.  The 
efficiency of 5-thio-D-glucose in  competing with  2-deoxy-D-glucose, combined 
with the failure of trioses to support cytolysis, seems to indicate that D-glucose 
is used in the cytolytic process either as intact hexose or an early modification 
of hexose. 
This argument implies that the role of D-glucose at the lethal hit stage is 
unrelated to  the capacity of this compound to  act as  an energy source. The 
experiments shown in Table IV indicate that pyruvate is a perfectly good source 
of energy (ATP generation) in sensitized spleen cells as a  whole. There is no 
good reason to suppose that the cytolytic T cells in this cell mixture should not 
also be able to derive energy from pyruvate by aerobic metabolism. However, 
pyruvate does not support cytolysis. Also, the aerobic metabolic pathways are 
not blocked by 2-deoxy-D-glucose (24) which is able to inhibit cytolysis. These 
results  indicate that  energy provision  alone is  not sufficient for cytolysis to 
proceed in simple salt solutions. 
Is energy required at all for T-cell-mediated cytolysis? Most published work 
on this question involves the use of metabolic inhibitors. Iodoacetate has been 
shown to block T-cell-mediated cytolysis at -  10  -4 M (3, 26). This concentration 
of drug does block lactate  production  in  sensitized  spleen cells,  but  fails to 
inhibit aerobic metabolism.  3 Table I clearly indicates that Krebs cycle activity 
becomes the major source of energy at low glucose concentrations, so it is hard 
to conclude that iodoacetate is acting by blocking energy supplies necessary for 
cytolysis. This conclusion is reinforced by the observation that pyruvate fails to 
reverse the effect of this  drug  (3). These experiments as  well as those with 
DFBS (Fig. 7) indicate that cytolysis can occur where net lactate accumulation 
is unmeasurable. Sodium azide in normal culture medium causes 50% block of 
cytolysis at -  30 mM (3, 26-28).  This concentration of azide is approximately ten 
times that required to  cause an equivalent inhibition of 6-C  CO2  production 
from glucose, but it is insufficient to inhibit glycolysis.3 However, in the absence 
of exogenous glucose but in the presence of DFBS, i.e. under conditions that we 
found led to  no detectable accumulation of lactate,  cytolysis was blocked by 
concentrations of aside  equivalent to  those required to  inhibit  the terminal 
cytochrome system (4), which seems to indicate a minimal energy requirement 
for cytolysis. 
The finding that 2-deoxy-D-glucose does not inhibit the formation of reduced 
NADP by the first two stages of the pentose cycle is of interest. Granulocytes 
undergo a burst of pentose-cycle activity during phagocytosis (29). It has been 
suggested that reduced NADP plays a vital role in the production of  bactericidal 
products,  particularly hydrogen peroxide (30). However, Michl et al.  (31,  32) 
have shown that phagocytosis, but not binding of C3 and IgG-coated erythro- 
cytes by mouse peritoneal macrophages, is blocked by 2-deoxy-D-glucose. This 
effect appeared to be independent of ATP production.  These authors showed 
that 2-deoxy-D-glucose did not inhibit opsonin-independent phagocytosis of latex 
particles,  which suggests that  this block may be  interfering with  a  specific 
recognition process. It will be interesting to see if comparative studies show any 
3 I.  C.  M.  MacLennan and P.  Golstein.  1978.  Manuscript in preparation. 1564  HEXOSE  REQUIREMENT  FOR  T-CELL-MEDIATED  CYTOLYSIS 
close similarities between this block on phagocytes compared with that seen on 
T-cell-mediated cytolysis. Our data do not exclude a role for NADPH, but they 
do  show  that  the  2-deoxy-D-glucose  inhibition  is  not  due  to  prevention  of 
reduction of this coenzyme. NADPI-I could potentially act as an energy source if 
it were transported  to mitochondria.  However, there  is no evidence that this 
occurs in cytotoxic T cells. Indeed, the experiment shown in Table IV suggests 
that  NADPH may be accumulating  in the cytoplasm.  This experiment  shows 
that pyruvate potentiates the production of 1-C.CO2 from glucose, and this may 
be because pyruvate can oxidize NADPI-I either  by combination  with CO2 to 
produce malate  (33) or by reduction of pyruvate to lactate (34). The removal of 
NADPH is important,  as this substance acts as a feedback inhibitor of glucose- 
6-phosphate oxidation by glucose-6-phosphate dehydrogenase (35). 
How then is D-glucose acting in the cytolytic process, and how is 2-deoxy-D- 
glucose interfering  with it? One of the actions of 2-deoxy-D-glucose which has 
recently  received much  attention  has  been  its  effect on  the  glycosylation of 
proteins.  Eagon and Heath  (36) showed that a  K  light chain made by BALB/c 
plasmacytoma cells cultured in 2-deoxy-D-glucose was synthesised and secreted 
without  its  carbohydrate  side  chain.  These  authors  showed  that  2-deoxy-D- 
glucose  inhibited  the  incorporation  of glucosamine,  mannose,  and  galactese, 
which seems to indicate that this inhibitor has a broad range of action on hexose 
incorporation  with  glycoproteins.  Hughes  et  al.  (37)  demonstrated  a  similar 
broad specificity of action of 2-deoxy-D-glucose in inhibiting  protein glycosyla- 
tion  by hamster  kidney  cells.  However,  Meager  et  al.  (38),  using  the  same 
system, showed less inhibition of mannose incorporation than glucosamine and 
galactose. Mannose, as well as glucose, was found by MacDonald to reverse the 
2-deoxy-D-glucose block of T-cell-mediated cytolysis (6). It has been shown that 
2-deoxy-D-glucose interferes  with  virus-induced  cell  fusion  (39).  This  effect is 
also reversed by mannose  and  glucose.  Thus,  the processes involved in these 
cases seem to exhibit similar  specificity for glucose,  mannose,  and  2-deoxy-D- 
glucose. 
It has been suggested that the impairment of cell fusion mentioned above may 
be due to a  lack of replacement of shed surface glycoproteins, which is in line 
with a  glycoprotein requirement for virus-induced cell fusion.  For T-cell-medi- 
ated cytolysis at the lethal hit stage, a glycoprotein may also be required, syn- 
thesized by glycosylation of a  preformed protein either in permanence  or only 
upon a post-recognition activation process. This glycosylation step could be the 
one which is inhibited by 2-deoxy-D-glucose. Alternatively, this agent could in- 
hibit  another  hexose-specific molecular recognition  step occurring  during  the 
lethal hit.  Whatever the proposed mechanism,  it would have to fit in with the 
alterations  of hexose  concentration  requirement  observed  in  the  presence  of 
FBS. 
Models such as these are of some help in designing further experiments to 
probe the mechanism of the lethal hit in T-cell-mediated cytolysis. These models 
must now take into account not only the fact that this stage of the lytic process 
is  dependent  on  calcium  ions  and  is  sensitive  to  agents  such  as  azide  and 
iodoacetate, but also that it has a requirement for hexose which is independent 
of its capacity to act as an energy source. IAN  C.  M.  MacLENNAN  AND  PIERRE  GOLSTEIN  1565 
Summary 
The requirement for D-glucose in T-cell-mediated cytolysis was studied using 
mouse spleen cells sensitized against alloantigens in vitro. Glucose was required 
for cytolysis: (a) cytolysis proceeded in a simple buffered salt solution containing 
Ca  ++ and Mg  ++  (low phosphate-buffered saline, LPBS) in the presence but not 
in the  absence of added glucose;  (5)  2-deoxy-D-glucose blocked cytolysis. The 
block by this  agent was  overcome by excess glucose added as late  as  40 rain 
after the inhibitor.  This block was not due to inhibition of NADP reduction, 
since 2-deoxy-D-glucose failed to interfere with the rate of CO~ production by the 
pentose cycle which we found to be of significant activity in sensitized spleen 
cells; (c) dialyzed fetal bovine serum (DFBS) in LPBS supported cytolysis in the 
absence of added glucose. However, 2-deoxy-D-glucose was also inhibitory under 
these  conditions,  suggesting  that  carbohydrate  was  required  here  as  well. 
Further results supported the conclusion that DFBS was not acting as a direct 
source of the required carbohydrate. 
The relationship between cytolysis, glucose requirement,  and  provision of 
energy was studied. As little as 0.1 mM D-glucose in LPBS supported cytolysis. 
At this glucose concentration, there was no measurable accumulation of lactate 
in  sensitized spleen  cells,  but  Krebs cycle activity was  detectable.  In  3  mM 
glucose or above, the range covered by standard tissue culture media, anaerobic 
glycolysis became a  major source of energy in sensitized spleen cells.  Conse- 
quently, it appears that in standard tissue culture medium, effector cells can 
generate sufficient energy for cytolysis either by aerobic or anaerobic metabo- 
lism.  However, the addition of an energy source alone in the absence of glucose 
was insufficient to support cytolysis in LPBS. Pyruvate in LPBS did not support 
cytolysis but  was  shown  to  be  a  good  substrate  for  aerobic  metabolism  in 
sensitized  spleen  cells.  Glycogenic  amino  acids  and  glycerol  also  failed  to 
support cytolysis. 
The stage of cytolysis at which glucose is required was investigated. Glucose 
was  necessary  for  the  calcium-dependent  lethal  hit  phase,  but  not  for  the 
cytochalasin A-blockable recognition stage,  nor for ~Cr  release from injured 
target cells. Models for the lethal hit process are discussed, which are compati- 
ble  with  the  observed  requirement  for  certain  hexoses  unrelated  to  their 
capacity to serve as sources of energy. 
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